or Try an Advanced Search...

    ETF Components for IHE - iShares U.S. Pharmaceutical ETF


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    JNJ D 0.00 22.25
    LLY F 0.00 20.67
    BMY B 0.00 5.27
    VTRS A 0.00 4.69
    PFE F 0.00 4.38
    ZTS D 0.00 4.32
    CTLT D 0.00 4.23
    RPRX D 0.00 4.18
    MRK F 0.00 4.09
    ITCI B 0.00 3.33

    Represented by ETF Holdings

    Keywords: S&P 500 Pharmaceutical Products Animal Health Biopharmaceutical Depressive Disorder Alzheimer's Disease Biotechnology Diabetes Dysfunction Health Products Hypertension Infectious Diseases Major Depressive Disorder Medication Neuroscience Schizophrenia Animal Health Products Anti Infectives Antibiotics Biopharmaceutical Products
    Industries: Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Biotechnology

    Recent News for iShares U.S. Pharmaceutical ETF & its Holdings

    Date Stock Title
    Nov 21 VTRS Viatris Inc. (VTRS) Management Presents at Jefferies London Healthcare Conference (Transcript)
    Nov 20 LLY Jim Cramer on Eli Lilly and Company (LLY): ‘I’m Kind Of Blown Away’
    Nov 20 ZTS Zoetis Inc. (ZTS) Management presents at Jefferies London Healthcare Conference (Transcript)
    Nov 20 PFE CDC warns of an imminent spike in COVID, flu cases
    Nov 20 MRK Merck Foundation Announces $17 Million U.S. Initiative To Expand Access to High-Quality Cardiac Care
    Nov 20 JNJ Update: Market Chatter: Johnson & Johnson, Merck Cut Jobs in China
    Nov 20 LLY Eli Lilly in pact with Chinese biotech for novel weight loss therapy
    Nov 20 MRK Merck & Co., Inc. (MRK)’s Blockbuster Drugs: A Key Player in Ken Griffin’s Portfolio
    Nov 20 PFE 5 Year-to-Date Laggards to Buy Amid Solid Near-Term Upside Potential
    Nov 20 LLY More companies covering weight loss drugs for their employees
    Nov 20 LLY Weight loss drug makers want more insurance plans to cover Wegovy and Zepbound
    Nov 20 PFE Pfizer Appoints Cancer Research Head Chris Boshoff as New R&D Chief
    Nov 20 CTLT Morgan Stanley lists hedge funds’ largest Q3 ownership increases in Russell 1000 stocks
    Nov 20 LLY China-based biotech Laekna teams up with Lilly to develop muscle preserving obesity drug
    Nov 20 PFE Bayer Acquires Rights for Cardiovascular Drug From CYTK in Japan
    Nov 20 LLY Eli Lilly Option Trade Produces $1,125, If You Can Tolerate The Heavy Risk
    Nov 20 PFE Pfizer names head of oncology as new R&D chief
    Nov 20 PFE Pfizer Announces New Chief Scientific Officer and President, Research & Development
    Nov 20 PFE Pfizer names oncology head Chris Boshoff as R&D chief
    Nov 20 PFE Pfizer Names New R&D Chief
    The investment seeks to track the investment results of an index composed of U.S. equities in the pharmaceuticals sector. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. It seeks to track the investment results of the Dow Jones U.S. Select Pharmaceuticals Index (the "underlying index"), which measures the performance of the pharmaceuticals sector of the U.S. equity market. The fund is non-diversified.
    Exchange Traded Fund ETF
    Back to the Main IHE Page...